This inventor holds 6 USPTO granted patents. Top assignee: University of California. Active years: 1997-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-2006
Title: David R Bentley: Innovator in Neurological Research
Introduction
David R Bentley is a prominent inventor based in Berkeley, CA (US). He has made significant contributions to the field of neurological research, holding a total of 6 patents. His work focuses on the semaphorin gene family, which plays a crucial role in nerve cell growth and regeneration.
Latest Patents
Bentley's latest patents include groundbreaking discoveries related to semaphorins. These patents disclose a novel class of proteins, semaphorins, along with nucleic acids encoding these proteins and semaphorin peptides. The inventions provide pharmaceutical compositions and methods for screening chemical libraries for regulators of cell growth and differentiation. Additionally, semaphorin gene-derived nucleic acids are proposed for use in genetic mapping, as probes for related genes, and as diagnostic reagents for genetic neurological diseases. The patents also detail specific cellular and animal systems aimed at developing therapies for neurological diseases.
Career Highlights
David R Bentley is affiliated with the University of California, where he continues to advance research in his field. His innovative work has garnered attention and respect within the scientific community, contributing to the understanding of neurological conditions and potential treatments.
Collaborations
Bentley has collaborated with notable colleagues, including Corey S Goodman and Alex L Kolodkin. These partnerships have further enriched his research and expanded the impact of his inventions.
Conclusion
David R Bentley's contributions to neurological research through his patents on semaphorins highlight his role as a leading inventor in the field. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
